Login

James P. Scriven, CEO of IDB Invest, shares insights on Latin American finance and development with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Finder Energy's CEO Damon Neaves on Transformative Acquisition and Fast-Tracked Development in Timor-Leste | Damon Neaves, CEO, Finder Energy Holdings Ltd.
00:10:00
Greg Fleming, president and CEO of Rockefeller Capital Management and former president of Morgan Stanley Wealth Management, is a prominent figure in the financial industry, known for his strategic leadership and expertise in wealth management.|Gregory J.
00:10:00
Speaking on succession planning, diversity, and the Flender spinoff is Siemens CEO Kaeser. | Philip J. Scherman, CEO, CES Energy Solutions CorpCESDF:PKC
00:10:00
Strategic Investment Insights on Inflation and Real Assets
00:10:00
The Importance of Fact-Based Policy for American Voters|Michael Boskin
00:10:00
JLL CEO Reflects on Transformative Leadership and Digital Evolution | Christian Ulbrich, CEO,  JLL Partners.
00:10:00
Interview with Norm Williams of Rambler Metals and Mining at One-to-One Mining Conference
00:10:00
Helix Resources: Unlocking High-Grade Copper Potential in Central Australia
00:00:00
Dr. Tim Rodell, M.D., CEO and Director at Aethlon Medical, Inc
00:10:00
Marc Halbfinger, CEO of PCCW Global, delivers a compelling testimonial at PTC, highlighting his vision and leadership.|Mr Li was appointed an Executive Director and the Chairman of PCCW
00:00:00
Silence Therapeutics - The GOLDen future of RNAi Research - Mark Rothera, President and CEO of Silence Therapeutics
00:10:00
Interview with Ian: New Gold Discovery in Tanzania and Future Prospects

© 2026 Nehu